![Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places](https://www.researchgate.net/profile/Norbert_Pardi/publication/340313439/figure/fig1/AS:875943132413958@1585852525943/figure-fig1_Q320.jpg)
Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places
![Nanomaterials | Free Full-Text | Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives | HTML Nanomaterials | Free Full-Text | Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives | HTML](https://www.mdpi.com/nanomaterials/nanomaterials-10-00364/article_deploy/html/images/nanomaterials-10-00364-g002.png)
Nanomaterials | Free Full-Text | Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives | HTML
![PDF) Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses PDF) Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses](https://i1.rgstatic.net/publication/316527213_Preclinical_and_Clinical_Demonstration_of_Immunogenicity_by_mRNA_Vaccines_against_H10N8_and_H7N9_Influenza_Viruses/links/59025d0b4585156502a302cd/largepreview.png)
PDF) Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
![Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5ad0596c-a47e-4554-afb8-a0c3fd4fa441/anie202008319-fig-0001-m.jpg)
Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library
![Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post](https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/722KMCAHLEI6XBYZBXYVTUKHSQ.jpg)
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
![A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7392193/bin/gr2_lrg.jpg)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
![COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma](https://qtxasset.com/fiercepharma/1597166780/coronavirus.jpg?BmcQIKzuQ5aqGswWWQ2D4IklxjT_mLZE)